Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects
A Randomized, Double-Blind, Placebo- and Active-Controlled, 4-Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects
Sponsor: Eisai Inc.
A PHASE1 clinical study on Healthy Participants, this trial is completed. The trial is conducted by Eisai Inc. and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Jun 2018 — Oct 2018 [monthly]
Completed PHASE1
▶ Show 5 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jun 2017 — Dec 2017 [monthly]
Completed PHASE1
-
Apr 2017 — Jun 2017 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eisai Inc.
- Purdue Pharma LP
For direct contact, visit the study record on ClinicalTrials.gov .